About
Haleon PLC generates revenue through its diverse portfolio of personal healthcare products across five categories: oral health, vitamins, minerals, and supplements (VMS), pain relief, respiratory health, and digestive health. The company sells branded products like Sensodyne, Polident, Parodontax, and Biotene for oral care; Centrum, Emergen-C, and Caltrate for VMS; Otrivin, Theraflu, and Flonase for respiratory health; Voltaren, Panadol, and Advil for pain relief; and TUMS, ENO, and Fenistil for digestive health. These products are sold globally across North America, Europe, Middle East, Africa, Latin America, and Asia Pacific, with respiratory health solutions targeting colds, flu, congestion, coughs, and allergies. Haleon's brands cater to consumers seeking over-the-counter healthcare solutions for daily health needs. Haleon's product segments align with consumer demand for accessible personal healthcare, with key brands like Centrum for vitamins, Advil for pain management, and Flonase for respiratory issues. The company operates in multiple regions, including EMEA and LatAm, where respiratory and digestive health products are particularly popular. Its portfolio includes both well-established brands and newer offerings, ensuring broad market coverage across different health categories and geographic markets. The company's revenue streams are driven by the consistent purchase of over-the-counter healthcare products by consumers in all major global markets. Haleon's brands, such as Sensodyne for sensitive teeth and TUMS for indigestion, are sold through retail channels and directly to consumers, supporting steady demand. With a focus on health categories like respiratory, digestive, and oral care, Haleon targets everyday health concerns across its global segments, ensuring recurring revenue from established product lines.
Annual results
Reported figures, GBP · revenue down 1.8% in 2025
| Year | Revenue | Net income | Net margin | Free cash flow |
|---|---|---|---|---|
| 2025 | 11.0B | 1.7B | 15.1% | — |
| 2024 | 11.2B | 1.4B | 12.8% | — |
| 2023 | 11.3B | 1.0B | 9.3% | — |
| 2022 | 10.9B | 1.1B | 9.8% | — |
| 2021 | 9.5B | 1.4B | 14.6% | — |
Dividends per share
HLN.L in MarketPulse
The live chart with RSI and moving averages, the price, news, signals and price alerts for Haleon PLC are inside MarketPulse — currently in private beta.
Company data by Eulerpool. Logos provided by Elbstream. Reported figures, not investment advice.